Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
THAP domain-containing protein 8 (THAP8) is a human protein characterized by the presence of a THAP domain—a conserved, zinc-dependent, sequence-specific DNA-binding domain belonging to the zinc-finger superfamily[1][2]. The THAP protein family is mainly restricted to animals and includes approximately a dozen members in humans, each with potentially distinct physiological functions. While the precise biological functions of THAP8 itself are not fully defined, THAP domain proteins as a group have been implicated in DNA binding, possible transcriptional regulation, and roles in cell proliferation, apoptosis, cell cycle modulations, and chromatin modification[1][2][3]. For THAP8, there is predictive evidence for roles in DNA binding and metal ion (zinc) binding[4]. Disease association has been described for primary autosomal recessive microcephaly; however, detailed molecular mechanisms and broader disease implications remain largely unknown[4]. Presently, THAP8 is not recognized as a validated therapeutic target, nor are there drugs or biomarkers specifically linked to its modulation or activity in clinical contexts[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on THAP domain-containing protein 8 (THAP8).